Literature DB >> 12497155

Cell adhesion and chemotaxis in prostate cancer metastasis to bone: a minireview.

C R Cooper1, K J Pienta.   

Abstract

Bone metastasis is a common phenomenon in patients with advanced prostate cancer. The molecular and cellular mechanisms involved in this process are not well understood. Past reviews on this subject primarily focused on prostate tumor growth in the bone marrow and the effects this growth has on bone homeostasis (ie osteoblastic and osteolytic). Cell chemotaxis and adhesion are also important for site-specific metastasis. In this review we have focused on chemotactic and cell adhesion molecules potentially involved in prostate cancer metastasis to bone. In addition, recently developed animal models for prostate cancer metastasis to bone are discussed. Prostate Cancer and Prostatic Diseases (2000) 3, 6-12

Entities:  

Year:  2000        PMID： 12497155     DOI： 10.1038/sj.pcan.4500387

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN： 1365-7852            Impact factor:   5.554


  20 in total

Review 1.  The role of alpha(v)beta(3) in prostate cancer progression.

Authors:  Carlton R Cooper; Christopher H Chay; Kenneth J Pienta
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.

Authors:  Deborah A Bradley; Stephanie Daignault; Charles J Ryan; Robert S Dipaola; Kathleen A Cooney; David C Smith; Eric Small; Paul Mathew; Mitchell E Gross; Mark N Stein; Alice Chen; Kenneth J Pienta; June Escara-Wilke; Gerald Doyle; Mahmoud Al-Hawary; Evan T Keller; Maha Hussain
Journal:  Invest New Drugs       Date:  2010-03-25       Impact factor: 3.850

Review 3.  Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.

Authors:  Thomas J Wilson; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2007-11-26

4.  Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis.

Authors:  Lisa Pham; Lisa Christadore; Scott Schaus; Eric D Kolaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

5.  The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines.

Authors:  Carlton R Cooper; Jasmine K Bhatia; Heather J Muenchen; Lisa McLean; Satoru Hayasaka; Jeremy Taylor; Paul J Poncza; Kenneth J Pienta
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 6.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

7.  Revealing global regulatory perturbations across human cancers.

Authors:  Hani Goodarzi; Olivier Elemento; Saeed Tavazoie
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

8.  Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo.

Authors:  Robert D Loberg; LaShon L Day; Rodney Dunn; Linda M Kalikin; Kenneth J Pienta
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

9.  Mesenchymal migration as a therapeutic target in glioblastoma.

Authors:  Jessie Zhong; Andre Paul; Stewart J Kellie; Geraldine M O'Neill
Journal:  J Oncol       Date:  2010-06-21       Impact factor: 4.375

10.  Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis.

Authors:  Lara H El Touny; Partha P Banerjee
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.